Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01619553 · ClinicalTrials.gov registry record
Genetic Analysis of Keloids
A clinical trial of Keloid, sponsored by UConn Health.
- Recruiting
- Registry status
- 7,000
- Enrollment target
- 1
- Study location
NCT01619553: Recruiting study of Keloid, sponsored by UConn Health.
NCT01619553 is a study of Keloid that is actively recruiting participants, run by UConn Health. The registered enrollment target is 7,000 participants, above the 1,269-participant average among 8 other Keloid trials with a reported enrollment target (452% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01619553, a study of Keloid, is actively recruiting participants, sponsored by UConn Health.
- RECRUITING
- Registry status
- 7,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Keloids have a strong genetic component. The goal of this study is to identify genes and regulatory elements on chromosomes that are the cause for keloids or contribute to keloid scarring.
Primary Outcome
The goal is to identify relevant genes or genetic elements that cause the disease or contribute to the disease progression and severity.
Conditions Studied
Study Locations (1)
Connecticut
- University of Connecticut Health Center (UCHC) - Farmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,000 participants |
| Start Date | 2009-04 |
| Est. Completion | 2025-12 |
What NCT01619553 shows while recruiting
NCT01619553 is an observational study that tracks outcomes without assigning an intervention. Its 7,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,269-participant average among 8 other Keloid trials with a reported enrollment target (452% higher).
The record links to 1 condition, with Keloid appearing as the primary indexed condition, and to 0 interventions.
NCT01619553 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT01619553 about?
NCT01619553 is a clinical study titled "Genetic Analysis of Keloids". Keloids have a strong genetic component. The goal of this study is to identify genes and regulatory elements on chromosomes that are the cause for keloids or contribute to keloid scarring.
What is the current status of trial NCT01619553?
This trial is currently recruiting. The enrollment target is 7,000 participants. The study started on 2009-04. Estimated completion is 2025-12.
What conditions does trial NCT01619553 study?
This clinical trial studies the following conditions: Keloid.
Who is sponsoring clinical trial NCT01619553?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01619553 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Keloid
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01619553's enrollment target sits among peer trials
7,000 2nd of 8 the highest of 8 other Keloid trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Keloid trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy
RECRUITING · Phase 2
-
Radiotherapy for Keloids
RECRUITING · NA
-
Web Based Investigation of Natural History of Keloid Disorder, an Online Survey
RECRUITING
-
RAPA-Keloid Study of Keloid Regression
COMPLETED · Early Phase 1
-
Examining the Therapeutic Potential of Botulinum Toxin Type A in the Treatment of Keloids
COMPLETED · Early Phase 1
-
Pilot Study Investigating a Restorative Wound Care Cream Together With Petrolatum on Surgical Excisions
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00260585 · 7,000 participants
Esophageal Cancer Risk Registry
- NCT04118660 · 7,000 participants
Thoracic Specimen Registry
- NCT07106879 · 7,000 participants
Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.
- NCT07140744 · 7,000 participants · NA
A Study Evaluating the Impact of P-tau217 Blood Biomarker Testing on Early Evaluation and Management of Patients Presenting With Cognitive Complaint
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia